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ABSTRACT 
Emerging viruses cause a lot of fatalities as they jump to humans from other species. Here we develop 
a novel technique to computationally estimate an important parameter of within-host viral infection: 
the lifespan of infected cells. Our approach is general and can be applied to a large class of viruses 
and leverages experimental data from replicon studies. Current techniques have difficulties reliably 
estimating infected cell lifetimes due to parameter identifiability and correlation of parameters. The 
infected cell lifetime is an important parameter that gives an estimate of how fast virus levels will 
decline. Our method would also help determine if some infected cells are short-lived or have longer 
lifespans with the consequence that longer lived cells could be reservoirs of infection. This would 
give a mechanistic understanding of why particular cell types are reservoirs of infection and may 
motivate therapy targeted towards these cell types. We apply our technique to West Nile virus 
(WNV), an emerging disease of public health relevance related to Zika virus. Our analysis suggests 
that the most abundant infectible cells are short-lived and could motivate therapy that targets these 
particular cells. Our approach is very general and can be combined with more traditional methods of 
using differential equation models to simulate viremia in hosts: the combination of these two 
techniques will likely yield results that may not be achievable using the models in isolation. This will 
be of great interest especially in modelling emerging diseases.  
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Emerging viruses cause a lot of fatalities as they jump to humans from other species. 
Accurate estimates characterizing the dynamics of the effects of the virus within hosts would 
give insights into the disease. Here we develop a novel technique to computationally estimate 
an important parameter of within-host viral infection: the lifespan of infected cells. This is 
difficult to directly estimate based on only in-vivo (within animals) experiments. Our 
approach is general and can be applied to a large class of viruses and leverages experimental 
data from replicon studies. Mathematical models have provided important insights into 
within-host viral dynamics. For example, human immunodeficiency virus (HIV) infection 
was modeled to analyze dynamics of the virus in patients which led to estimates of the in-
vivo rate of HIV replication and the average life span of productively infected cells [1-4]. 
These models gave insights into how the virus remained quiescent for years before leading to 
detectable symptoms. Our primary goal is to outline a novel computational technique to 
characterize in-vivo productively infected cell lifetimes. Our computational technique 
leverages advances in genetically modified viruses called replicons. Our approach can 
complement existing techniques using differential equations and help overcome issues of 
parameter identifiability and correlation of parameters [5]. The infected cell lifetime is an 
important parameter that gives an estimate of the how fast virus levels will decline following 
treatment with antivirals [4]. Accurate estimates of infected cell lifetimes would also be able 
to suggest if certain long lived cells could be reservoirs of infection. We motivate our 
analysis by applying our technique to an emerging disease: West Nile virus (WNV), which 
infects multiple species including humans and has caused high fatalities [6-8]. It is an 
arbovirus and is in the same family as other viruses such as Zika and hepatitis C virus which 
are of significant public health concern. Our analysis suggests that the most abundant 
infectible cells are short-lived (most likely dendritic cells and macrophages) and could 
motivate therapy that targets these particular cells. We suggest that our approach is very 
general and can be combined with more traditional methods of using differential equation 
models to estimate viral parameters within hosts [5]: the combination of these two techniques 
will likely yield results that may not be achievable using the models in isolation. This will be 
of great interest in modelling emerging diseases of public health significance.  
MATERIALS AND METHODS 
STUDY DATA 
We use data on in-vivo infection of B6 mice with WNV replicons [9]. The WNV replicon 
was genetically engineered to encode a Renilla luciferase reporter and had the genes 
encoding for WNV structural proteins deleted. Viral structural proteins were packaged in 
trans to create virus-like particles as described in [10]. The WNV replicon was injected 
subcutaneously into the footpad of six week old B6 mice. At various time points, the draining 
popliteal lymph node was harvested, homogenized and assayed for luciferase activity.  
RESULTS 
ANALYSIS OF DATA ON IN-VIVO INFECTION USING A WNV REPLICON  
We analyzed data on in-vivo infection of B6 mice with WNV replicons [9]. Replicons are 
synthetically modified viruses and in this experiment they were modified:  
1) to express a gene for bioluminescence so that virus activity could be monitored, and  




Translation of the gene for bioluminescence produces luciferase within the infected cell 
which converts a substrate to photons. The activity or expression of the luciferase reporter 
was monitored regularly. This study has several features which help us get constraints on 
productively infected cell lifespans: 
1) The WNV replicon kills cells in-vitro and also presumably in-vivo (personal communication 
Dr. Kristen Bernard, University of Wisconsin-Madison). We note however that insertion of the 
gene for Renilla luciferase into the WNV genome could negatively impact replication efficiency. 
2) WNV replicon leads to only a single round of infection in cells. 
3) The luciferase reporter is not secreted. Hence we only have to consider intracellular decay 
of luciferase and not clearance of luciferase outside cells (by the action of blood,  
extra-cellular degra- dation, etc). 
We note the caveat that since the viral structural genes are deleted, there is no viral budding 
from infected cells and hence cytopathicity can be lower than due to the full length virus. The 
cells in the draining popliteal lymph node are likely dendritic cells and macrophages 
(personal communication, Dr. Kristen Bernard). The decline in luciferase reporter expression 
late in the infection is due to:  
a) killing of cells in-vivo by WNV replicon leading to a decline in luciferase expression,  
b) decay of luciferase within the cell,  
c) migration of replicon infected dendritic cells and macrophages out of the draining lymph 
node and  
d) inhibition of replicon replication by cellular interferon. 
One study observed a small dendritic cell population in thoracic duct lymph that had 
presumably migrated from the lymph node and measured it to be a very small percentage 
(approximately 0,013 %) of all viable cells [11]. It is also not completely understood whether 
and how dendritic cells exit the lymph node [12]. Hence in what follows, we ignore migration 
of infected dendritic cells and macrophages from the draining lymph node. We represent the 
dynamics of luciferase activity in the declining phase by the following model: 
  
 , (1) 
 . (2) 
Cells that are infected with the replicon and actively producing luciferase intracellularly are 
represented by I2. Productively infected cells (I2) die at a rate δ per cell because of the WNV 
replicon, where 1/δ is the average life span of a productively infected cell. The kinetics of 
intracellular luciferase (L) is dictated by luciferase expression within productively infected 
cells (I2) mediated by a constant κ and intracellular decay at rate μ. Solving the equations 
above, assuming initial conditions L(0) = 0, leads to the following equation for the kinetics of 
luciferase expression within productively infected cells: 
 . (3) 
where a is a constant. Luciferase decays rapidly within cells with a half-life of approximately 2 
hours [13] yielding a decay rate (μ) of 8,3 / day. Because of this rapid decay, we can approximate 
the dynamics of intracellular luciferase after an initial transient phase by the following equation: 
 . (4) 
We fit Equation 4 to data in [9] (Figure 1) for the decaying phase of luciferase and estimate δ 
to be approximately 5.2 / day, giving us a mean productively infected lifespan (1 / δ) of 
approximately 5 hours (r
2
 = 0,85, ordinary least squares slope = -1,98). 
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We also developed the complete model (without approximating that luciferase decays 
rapidly) and explicitly simulate the decay of luciferase. We show the results of the simulation 
in Figure 2. We note that it does not change the results (produces the same estimate of cell 
lifetimes). It predicts an initial increase in observed luciferase due to the translation of 
replicons to luciferase. This can be verified experimentally if it is feasible to take 
measurements within a few hours of inoculation by replicons. 
In summary, our analysis of data from an in-vivo WNV replicon study suggests that cells in 
the draining lymph node, likely comprising dendritic cells and macrophages, have a 
productively infected cell lifespan of approximately 5 hours in mice. 
 
Figure 1. Equation 4 fit to data on luciferase activity in mice using a WNV replicon (data 
from [9]) (r
2
 = 0,85, ordinary least squares slope = -1,98). 
DISCUSSION AND CONCLUSION 
We describe a method to computationally estimate infected cell productively infected 
lifetimes based on experimental data for an emerging disease: West Nile virus (WNV). WNV 
is a flavivirus and is in the same family as other emerging diseases of public health concern 
such as Zika virus and hepatitis C virus. Our technique leverages data from a replicon system 
(synthetically modified virus) that encodes a gene for fluorescence which enables direct 
visualization of virus activity. We use a dynamical systems model to estimate an important 
biologically relevant parameter: the lifespan of infected cells that are producing virus. Having 
outlined our computational technique to infer infected cell lifetimes from a novel 
experimental dataset, we suggest how it can complement existing analysis of viral studies. 
We focus on West Nile virus (WNV) as a candidate system but a similar analysis can also be 
done for other viruses for which replicons can be engineered.  
WNV infects multiple cell types: some are short-lived and some have longer lifespans with 
the consequence that longer lived cells could be reservoirs of infection. Our analysis of in-
vivo infection data using WNV replicons (Figure 1) suggests that cells in the draining lymph 
node, likely comprising dendritic cells and macrophages, have a productively infected 
lifespan of approximately 5 hours.  
A previous mathematical model trained on infection data in mice (using a non-linear 
differential equation model of viral kinetics) predicts a productively infected cell lifetime of 2 
to 14 hours in-vivo. Our current analysis also supports this, suggesting that in-vivo lifetimes 




However, another study suggests that other cell types (keratinocytes) have longer 
productively infected lifespans in-vitro than our estimates in-vivo from mice [5].  
 
Figure 2. Simulation of complete system (Equation 3) over time (days) (explicitly modelling 
luciferase decay).  
Is it possible to reconcile all these studies? We suggest the possibility that cells with short 
productively infected cell lifespans (like dendritic cells and macrophages) contribute significantly 
more to viremia in serum in mice than keratinocytes with longer productively infected cell 
lifespans. That would explain the relatively short infected cell lifetime (2 to 14 hours) in 
previous models [5] since the short-lived cells (dendritic cells and macrophages) are possibly 
more abundant. There are likely more susceptible dendritic cells and macrophages in the 
lymph node, spleen and kidney than there are keratinocytes in skin. We can reason about this 
as a two compartment system: one compartment is long-lived but less abundant (comprised of 
keratinocytes) and another compartment is short-lived but abundant (comprised of macrophages 
and dendritic cells). Hence the short-lived cells could contribute more to viremia and 
estimates of lifetimes would be closer to the lifetimes of these cells (2 to 14 hours). 
This is akin to the situation in HIV, where infected CD4+ T-cells are short-lived and 
contribute significantly more to peripheral viral load than longer lived cell populations, such 
as macrophages [4]. Taken together with previous experimental results, our modeling 
suggests that cells with relatively short productively infected lifespans (likely dendritic cells 
and macrophages) in lymph node, spleen and kidney likely contribute significantly towards 
WNV viremia in serum during the acute phase of infection.  
This would also be consistent with studies that inhibited replication in dendritic cells and 
macrophages and observed reduction of WNV titer in serum to undetectable levels [14] (also 
personal communication Dr. Manjunath Swamy, Texas Tech University). We note however, 
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that keratinocytes also play a very important role in WNV pathogenesis. Long lived infected 
keratinocytes contribute towards persistent viremia in skin and peripheral organs months after 
infection, even well after viremia has declined to undetectable levels in serum [15]. Keratinocytes 
are also the initial targets of WNV infection [9] and promote migration of infected Langerhans 
cells to the draining lymph node [16], which in turn facilitates systemic spread of WNV [16]. 
In summary, our analysis suggests that the most abundant infectible cells in WNV are  
short-lived. These cells are most likely dendritic cells and macrophages and could be reservoirs 
of infection. This could motivate therapy that specifically targets these cells. Therapy during 
the acute phase of infection could be targeted towards short-lived cells (dendritic cells and 
macrophages) whereas therapy during the chronic phase can be directed towards keratinocytes. 
Our computational technique yields biological insights that complement approaches using 
differential equation models to fit viremia data [5]. This suggests a novel way to combine 
traditional differential equation models with models fit to replicon data and could be applied to 
other emerging diseases, e.g. Dengue virus for which replicons have also been constructed [17]. 
Finally, we note that we analyzed data from in-vivo infection of mice with WNV replicon 
particles modified to be capable of only one round of infection and encoding an intracellular 
luciferase reporter. The fact that these particles are capable of only round of infection and that 
they decay very rapidly in the intra-cellular environment is critical since it considerably 
reduces the parameters that need to be estimated. 
Our modeling makes suggestions for further experimental work. More frequent measurement of 
replicon and simultaneous measurements with viremia in serum (both in-vivo and in the same strain 
of mice) may help in getting more accurate estimates of biologically relevant model parameters. 
Our method is general and can be applied to other emerging viral infections where replicon 
experiments are feasible, e.g. in Dengue virus [17]. Our technique can complement current 
approaches using ordinary differential equations and can help overcome problems of 
parameter identifiability and correlation of parameters (like the lifetime of infected cells) [5]. 
The infected cell lifetime is an important parameter that gives an estimate of the how fast 
virus levels will decline following treatment with antivirals [4]. 
Accurate estimates of infected cell lifetimes can also suggest if some cell types are long-term 
reservoirs of infection as we have shown in the preceding analysis with WNV. This would 
give a mechanistic understanding of why particular cell types are reservoirs of infection and 
give insights into why some viruses seem to be specialized for certain cell types (cell tropism).  
Accurate estimates of infected cell lifetimes can also be compared to the theoretically predicted 
value for optimal propagation [18] giving insights into how far a given strain of virus is from 
mutating into a more virulent strain. Such an analysis can also be incorporated in scaling 
parameters of disease progression between hosts [19]. This would enable us to couple within 
host models of viral kinetics to models of how viruses spread between hosts, enabling modelling 
of diseases at multiple scales. Our work also suggests a generality and power of dynamical 
models in capturing rich features of diverse complex systems ranging from immune systems 
and intra-cellular regulatory networks to global scientific collaboration networks [20-34]. 
In summary we suggest that our approach is very general and can be combined with more 
traditional methods of using differential equation models to estimate parameters of viremia in 
hosts [5]: the combination of these two techniques will likely yield results that may not be 
achievable using these models in isolation. This will be of great interest especially in 
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